MARKET WIREBenzinga • 20h ago
11 Consumer Staples Stocks Moving In Tuesday's After-Market SessionBenzinga report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
Why RDGT Stock dropped -3.32% Today — RQD Quant Desk Flash
$0.80 -3.32% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.79
Ridgetech Inc. (RDGT) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $2.9M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on RDGT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is RDGT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Ridgetech Inc. (NASDAQ: RDGT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $0.80 (-3.32% 1D, market cap $2.9M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 5/20. Across 147 tracked Consumer Staples issuers, RDGT ranks #115 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does RDGT compare to YI and PETS in the Consumer Staples sector?
▼
Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), RDGT carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 3.6%, and ROIC of —. By comparison, YI (111 Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -20.5%, cap $25.1M) and PETS (PetMed Express Inc.) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.8M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for RDGT?
▼
Per RDGT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001856084), Ridgetech Inc. generated $132.2M in revenue (+10.2% YoY), -$1.3M in net income, and -$1.4M in free cash flow against $61.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.79 (-0.79%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.3% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-10% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for RDGT)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (36/100 Composite)
🔍 WHY RDGT SCORES 36/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+10/20 pts (28% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 3.6% Gross Margin
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (22% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 1/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)
Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$0.86-3.5% Next Q
44
Q2 (-2Q)Grade D$0.83+9.6% Next Q
41
Q3 (-1Q)Grade E$0.91-12.1% Next Q
39
CurrentGrade D-$0.80-8.3% Hist 90D α
36
Trajectory: D (44) → D- (36)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a RDGT Turnaround Squeeze
While RDGT currently carries a cautious 36/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Consumer Staples with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.88) and Max Pain ($0.84) forces dealer call-delta covering toward $798.52.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $RDGT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “RDGT Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why RDGT Stock dropped -3.32% Today — RQD Quant Desk Flash
Ridgetech Inc. (RDGT) dropped -3.32% to $0.80, trading at 2% of its 52-week range ($0.67 – $760.5). Stretched risk/reward at current multiples (3.6% gross margin) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.67 – $760.5) with RSI-14 at 44.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.80 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 3.6% gross margin and $0 annual free cash flow.
Live RDGT Headlines & Catalysts
MARKET WIREwww.siam.in • 23h ago
Ridgetech Inc. (RDGT) Shares Edge Higher, Up 2.82% to $0.87 - Ascending Trianglewww.siam.in report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
RISK WATCHhttps://www.dars.gov.et/ • 1d ago
Ridgetech (RDGT) Stock Today: Drops -10.63% — Critical Support Levels 2026-10-09 - Fear Greed Indexhttps://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
CATALYSTwww.dars.gov.et • 1d ago
Ridgetech (RDGT) Slips 3.32% to $0.80, Sitting Midway Between $0.76 Support and $0.84 Resistance - Growth Factorwww.dars.gov.et report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
CATALYSThttps://www.dars.gov.et/ • 1d ago
RDGT Q3 2011 Earnings: Shares Climb 15.45% Despite a 9.91% EPS Miss - EPS Growth Reporthttps://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 102d ago
Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical AssociationRidgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that its wholly owned offline pharmaceutical wholesale dist
MARKET WIREYahoo Finance • 213d ago
Ridgetech, Inc. Announces 1-for-150 Reverse Share SplitRidgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-15
MARKET WIREYahoo Finance • 95d ago
Ridgetech, Inc. Reports Fiscal Year 2026 Financial ResultsRidgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2
MARKET WIREYahoo Finance • 173d ago
12 Consumer Staples Stocks Moving In Wednesday's After-Market SessionGainers Edible Garden (NASDAQ:EDBL) stock moved upwards by 46.2% to $0.55 during Wednesday's after-market session. The company's market cap stands at $1.8 million. Grocery Outlet Holding (NASDAQ:GO) stock rose 19.99% to
CATALYSTYahoo Finance • 243d ago
Ridgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value CreationRidgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its dual-engine growth strategy for 2026. The strategy cent
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring RDGT)
- ✓Walkthrough of RDGT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
RDGT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -46.67%▼ SUPPORT BREAKDOWN
2026-11-03O $0.83H $0.83L $0.80C $0.80VOL 15.4K
RES: $0.98SUP: $0.80SMA50: $0.88SMA200: $64.23
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
RDGT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. +10.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on RDGT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for RDGT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for RDGT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (RDGT)
Consumer Staples Rank #115 of 147
⚔️ YI vs RDGT Full Matrix →
1. Head-to-Head Consumer Staples Peer Comparison (RDGT vs. YI, PETS, GRDN, CVS)
Industry: Retail-Drug Stores and Proprietary Stores (5 Tracked Issuers)Across 147 tracked Consumer Staples securities in the Roarable RQD universe, Ridgetech Inc. (RDGT) ranks #115 by composite RQD confidence (36/100, grade D-) and #141 by equity capitalization ($2.9M). Within this direct 5-issuer industry benchmark cohort, GRDN leads on earnings valuation at 52.1x trailing P/E, while GRDN leads on capital efficiency and profitability with 37.7% ROIC and 20.2% gross margin. GRDN currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with RDGT at 36/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| RDGT
ACTIVE
Ridgetech Inc. | D- | 36/100 | — | 3.6% | — | -3.32% | $2.9M | Benchmark Subject |
| YI 111 Inc. | D- | 37/100 | — | 5.8% | -20.5% | -4.36% | $25.1M | /yi-vs-rdgt → |
| PETS PetMed Express Inc. | E | 19/100 | — | 28.1% | -35.0% | +0.85% | $25.8M | /pets-vs-rdgt → |
| GRDN Guardian Pharmacy Services Inc. (Class A) | B- | 71/100 | 52.1x | 20.2% | 37.7% | +0.59% | $2.58B | /grdn-vs-rdgt → |
| CVS CVS Health Corporation | C- | 60/100 | 65.3x | 45.0% | 2.6% | -0.09% | $115.43B | /cvs-vs-rdgt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001856084 ↗In its most recent audited fiscal period (FY2025, filed 2026-03-31), Ridgetech Inc. (RDGT) reported GAAP revenue of $132.2M (+10.2% vs. FY2024 revenue of $120.0M , and +6.6% cumulative change since FY2023) , GAAP net income of -$1.3M, operating cash flow of -$1.4M, and free cash flow of -$1.4M (-227.6% YoY). On the balance sheet, RDGT closed FY2025 with $61.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-03-31 | $132.2M | -$1.3M | -$1.4M | -$1.4M | $61.4M | — |
| FY2024 (FY) | 2025-03-31 | $120.0M | $10.2M | $1.2M | $1.1M | — | — |
| FY2023 (FY) | 2024-03-31 | $124.0M | -$4.2M | -$3.2M | -$3.2M | — | — |
3. RDGT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs RDGT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Ridgetech Inc. (NASDAQ: RDGT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $0.80 (-3.32% 1D, market cap $2.9M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 5/20. Across 147 tracked Consumer Staples issuers, RDGT ranks #115 in composite RQD confidence.
How does RDGT compare to YI and PETS in the Consumer Staples sector?
Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), RDGT carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 3.6%, and ROIC of —. By comparison, YI (111 Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -20.5%, cap $25.1M) and PETS (PetMed Express Inc.) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.8M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for RDGT?
Per RDGT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001856084), Ridgetech Inc. generated $132.2M in revenue (+10.2% YoY), -$1.3M in net income, and -$1.4M in free cash flow against $61.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is RDGT trading relative to its 50-day, 200-day, and 52-week technical levels?
RDGT last traded at $0.80 (-3.32% on volume of 15,405 shares), positioning the stock -9.09% below its 50-day simple moving average ($0.88) and -98.75% below its 200-day simple moving average ($64.23). Across its 52-week range of $0.67 to $760.50, RDGT sits at the 0.0% percentile with a 14-day RSI of 44.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.90).
ROARABLE RATING BRIEF • RQD 36/100 (D-)
✓ SEC XBRL & RQD VERIFIED
RDGT — Ridgetech Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-03-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Ridgetech Inc. (RDGT) earns a live Roarable RQD composite score of 36/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $0.80 (-3.32% 1D, market capitalization $2.9M).
- Fundamental Cash Engine (10/20): Anchored by return on invested capital (ROIC) of —, gross margin of 3.6%, operating margin of -1.4%, and free cash flow yield of —.
- Whale 13F & Options Flow (6/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (7/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 1/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Ridgetech Inc. Is a NASDAQ-listed issuer classified in the Consumer Staples sector, within the Retail-Drug Stores and Proprietary Stores industry..0B.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-31), Ridgetech Inc. (RDGT) reported $132.2M in annual revenue (up from $120.0M in FY2024, +10.2% YoY) and -$1.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($124.0M revenue, -$4.2M net income) through FY2025, RDGT scaled operating cash flow to -$1.4M and free cash flow to -$1.4M, backed by $61.4M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D- • RQD 36/100): Established market leader in Consumer Staples with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 6/20. With Fundamental Cash Engine at 10/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $0.67 – $760.50 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -1.4% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Operating in Retail-Drug Stores and Proprietary Stores (Consumer Staples), RDGT carries a macro regime beta of 1.00 and gross margin of 3.6%.
- Key Question #1: Can RDGT sustain or expand its -1.4% operating margin and — ROIC against Retail-Drug Stores and Proprietary Stores peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $132.2M and free cash flow of -$1.4M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is RDGT's equity valuation to Consumer Staples capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
RDGT Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Ridgetech Inc. (RDGT) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Benzinga • 20h ago
11 Consumer Staples Stocks Moving In Tuesday's After-Market Session Benzinga report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE www.siam.in • 23h ago
Ridgetech Inc. (RDGT) Shares Edge Higher, Up 2.82% to $0.87 - Ascending Triangle www.siam.in report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH https://www.dars.gov.et/ • 1d ago
Ridgetech (RDGT) Stock Today: Drops -10.63% — Critical Support Levels 2026-10-09 - Fear Greed Index https://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST www.dars.gov.et • 1d ago
Ridgetech (RDGT) Slips 3.32% to $0.80, Sitting Midway Between $0.76 Support and $0.84 Resistance - Growth Factor www.dars.gov.et report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST https://www.dars.gov.et/ • 1d ago
RDGT Q3 2011 Earnings: Shares Climb 15.45% Despite a 9.91% EPS Miss - EPS Growth Report https://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 102d ago
Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that its wholly owned offline pharmaceutical wholesale dist
🟡 MARKET WIRE Yahoo Finance • 213d ago
Ridgetech, Inc. Announces 1-for-150 Reverse Share Split Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-15
🟡 MARKET WIRE Yahoo Finance • 95d ago
Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
RDGT Bull vs. Bear Conversation Board — What's Your Call at $0.80?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON RDGT 🐻 33% BEARISH CONVICTION
CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH
🎯 Target: $0.93 (+16.3%)
📌 Pinned Debate Price action shows documented upside moves, including a 2.82% gain to $0.87 and a 15.45% post-earnings share climb despite an EPS miss.
Picked up a starter position in RDGT in my $100K Virtual Cash book at $0.80. Price action shows documented upside moves, including a 2.82% gain to $0.87 and a 15.45% post-earnings share climb despite an EPS miss.. Trading inside a $0.67–$760.50 52-week range with 0.0% FCF yield gives solid downside support if Retail-Drug Stores and Proprietary Stores multiples expand this quarter.
VolSurface_Trader 🐂 BULL
@SkepticalCFA Shorting a 6/20 institutional whale-flow stock at $0.80 is dangerous when funds are rotating into Consumer Staples.
SK SkepticalCFA RQD DEBATE OPENER • Fundamental Contrarian 🐻 BEARISH
🎯 Target: $0.63 (-21.3%)
Spot @ $0.80 The RQD rating scores the forensic balance sheet at 8/20 with Piotroski F at 1/9, while ROIC and FCF yield are both 0%.
Here is the bear case nobody on the bull side wants to address on RDGT: The RQD rating scores the forensic balance sheet at 8/20 with Piotroski F at 1/9, while ROIC and FCF yield are both 0%.. At current EV/EBITDA multiples, even a small guidance miss in Retail-Drug Stores and Proprietary Stores triggers a 12-15% air pocket.